A Variant of Inv(3)(q21q26.2) or t(3;3)(q21;q26.2) (MECOM) Rearrangement in AML

被引:0
|
作者
Mueller, Rosemary
Wong, Olivia
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
48
引用
收藏
页码:244 / 244
页数:1
相关论文
共 50 条
  • [21] Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival in Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2); a Bone Marrow Pathology Group Study
    Rogers, H. J.
    Vardiman, J. W.
    Anastasi, J.
    Raca, G.
    Savage, N. M.
    Cherry, A. M.
    Arber, D.
    Moore, E.
    Morrissette, J. J. D.
    Bagg, A.
    Liu, Y-C
    Mathew, S.
    Orazi, A.
    Lin, P.
    Wang, S. A.
    Bueso-Ramos, C. E.
    Foucar, K.
    Hasserjian, R. P.
    Hsi, E. D.
    LABORATORY INVESTIGATION, 2013, 93 : 358A - 358A
  • [22] Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival in Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2); a Bone Marrow Pathology Group Study
    Rogers, H. J.
    Vardiman, J. W.
    Anastasi, J.
    Raca, G.
    Savage, N. M.
    Cherry, A. M.
    Arber, D.
    Moore, E.
    Morrissette, J. J. D.
    Bagg, A.
    Liu, Y-C
    Mathew, S.
    Orazi, A.
    Lin, P.
    Wang, S. A.
    Bueso-Ramos, C. E.
    Foucar, K.
    Hasserjian, R. P.
    Hsi, E. D.
    MODERN PATHOLOGY, 2013, 26 : 358A - 358A
  • [23] Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3
    Maria Raya, Jose
    Martin-Santos, Taida
    Luno, Elisa
    Sanzo, Carmen
    Luz Perez-Sirvent, Maria
    Such, Esperanza
    Tomas Navarro, Jose
    Milla, Fuensanta
    Alonso, Esther
    Domingo, Alicia
    Rozman, Maria
    Diaz-Beva, Marina
    Batlle, Ana
    Gonzalez-de-Villambrosia, Sonia
    Tuset, Esperanza
    Vallespi, Teresa
    Ortega, Margarita
    Bermejo, Alfredo
    Martin-Ramos, Marisa
    Peri, Valeria
    Sole, Francesc
    Florensa, Lourdes
    HEMATOLOGY, 2015, 20 (08) : 435 - 441
  • [24] Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study
    Rogers, Heesun J.
    Vardiman, James W.
    Anastasi, John
    Raca, Gordana
    Savage, Natasha M.
    Cherry, Athena M.
    Arber, Daniel
    Moore, Erika
    Morrissette, Jennifer J. D.
    Bagg, Adam
    Liu, Yen-Chun
    Mathew, Susan
    Orazi, Attilio
    Lin, Pei
    Wang, Sa A.
    Bueso-Ramos, Carlos E.
    Foucar, Kathryn
    Hasserjian, Robert P.
    Tiu, Ramon V.
    Karafa, Matthew
    Hsi, Eric D.
    HAEMATOLOGICA, 2014, 99 (05) : 821 - 829
  • [25] Clinical and Genomic Profiles of Korean Patients with MECOM Rearrangement and the t(3;21)(q26.2;q22.1) Translocation
    Lee, Jikyo
    Kim, Sung Min
    Kim, Soonok
    Yun, Jiwon
    Jeong, Dajeong
    Lee, Young Eun
    Roh, Eun-Youn
    Lee, Dong Soon
    ANNALS OF LABORATORY MEDICINE, 2022, 42 (05) : 590 - +
  • [26] Lenalidomide Plus Hypomethylating Agent for Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities -AML with Inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, Mecom
    Merz, Lauren E.
    Perissinotti, Anthony J.
    Marini, Bernard Lawrence
    Crouch, Ashley
    Pettit, Kristen
    Burke, Patrick W.
    Erba, Harry P.
    Bixby, Dale L.
    BLOOD, 2018, 132
  • [27] Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: A case report
    Lewen M.
    Gresh R.
    Queenan M.
    Paessler M.
    Pillai V.
    Hexner E.
    Frank D.
    Bagg A.
    Aplenc R.
    Caywood E.
    Wertheim G.
    Biomarker Research, 4 (1)
  • [28] Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols
    Sitges, Marta
    Boluda, Blanca
    Garrido, Ana
    Morgades, Mireia
    Granada, Isabel
    Barragan, Eva
    Arnan, Montserrat
    Serrano, Josefina
    Tormo, Mar
    Miguel Bergua, Juan
    Colorado, Mercedes
    Salamero, Olga
    Esteve, Jordi
    Benavente, Celina
    Perez-Encinas, Manuel
    Coll, Rosa
    Marti-Tutusaus, Josep-Maria
    Brunet, Salut
    Sierra, Jorge
    angel Sanz, Miguel
    Montesinos, Pau
    Ribera, Josep-Maria
    Vives, Susana
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 105 (02) : 138 - 147
  • [29] Lenalidomide Plus Hypomethylating Agent as a Treatment Option in Acute Myeloid Leukemia With Recurrent Genetic Abnormalities-AML With inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM
    Merz, Lauren E.
    Perissinotti, Anthony J.
    Marini, Bernard L.
    Burke, Patrick W.
    Crouch, Ashley
    Erba, Harry P.
    Bixby, Dale
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (01): : 24 - 30
  • [30] The prognostic significance of an inv(3)(q21q26.2) in addition to a t(9;22)(q34;q11.2) in patients treated with tyrosine kinase inhibitors
    Theil, Karl S.
    Cotta, Claudiu V.
    CANCER GENETICS, 2014, 207 (05) : 171 - 176